Title | Authors | Journal | Volume (Year) |
---|---|---|---|
Oncogenic role of miR-483-3p at the IGF2/483 locus. | Veronese A, et. al. | Cancer Res | 70 (2010) |
MDM2 antagonists activate p53 and synergize with genotoxic drugs in B-cell chronic lymphocytic leukemia cells. | Coll-Mulet L, et. al. | Blood | 107 (2006) |
Regulation of expression of BIK proapoptotic protein in human breast cancer cells: p53-dependent induction of BIK mRNA by fulvestrant and proteasomal degradation of BIK protein. | Hur J, et. al. | Cancer Res | 66 (2006) |